Type 1 Diabetes (T1D) Market Report

Europe Type 1 Diabetes (T1D) Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 23, 2020
  • PAGES：214
  • REPORT CODE：GMM445839
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Type 1 Diabetes (T1D) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Type 1 Diabetes (T1D) Market Segmentations:

    By Player:

    • Bristol-Myers Squibb

    • Sanofi

    • Eli Lilly

    • Astellas

    • Lexicon

    • Janssen

    • Samsung Bioepis

    • Merck

    • Boehringer Ingelheim

    • Sanofi

    • Janssen

    • Merck

    By Type:

    • Rapid Acting Insulin Analogs

    • Long Acting Insulin Analogs

    • Premix Insulin Analogs

    By End-User:

    • Children

    • Adults

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Type 1 Diabetes (T1D) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Rapid Acting Insulin Analogs from 2014 to 2026

    • 1.3.2 Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Long Acting Insulin Analogs from 2014 to 2026

    • 1.3.3 Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Children from 2014 to 2026

    • 1.4.2 Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Adults from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Type 1 Diabetes (T1D) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Type 1 Diabetes (T1D) by Major Types

      • 3.4.1 Market Size and Growth Rate of Rapid Acting Insulin Analogs

      • 3.4.2 Market Size and Growth Rate of Long Acting Insulin Analogs

      • 3.4.3 Market Size and Growth Rate of Premix Insulin Analogs

    4 Segmentation of Type 1 Diabetes (T1D) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Type 1 Diabetes (T1D) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Type 1 Diabetes (T1D) for Children

      • 4.4.2 Market Size and Growth Rate of Type 1 Diabetes (T1D) for Adults

    5 Market Analysis by Major Regions

    • 5.1 Europe Type 1 Diabetes (T1D) Production Analysis by Top Regions

    • 5.2 Europe Type 1 Diabetes (T1D) Consumption Analysis by Top Regions

    • 5.3 Europe Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Type 1 Diabetes (T1D) Market among Top Countries

    • 6.1 Top 5 Export Countries in Type 1 Diabetes (T1D) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Type 1 Diabetes (T1D) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Type 1 Diabetes (T1D) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Type 1 Diabetes (T1D) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Type 1 Diabetes (T1D) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Type 1 Diabetes (T1D) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Type 1 Diabetes (T1D) Landscape Analysis

    • 7.1 Germany Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 7.2 Germany Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    8. UK Type 1 Diabetes (T1D) Landscape Analysis

    • 8.1 UK Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 8.2 UK Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    9. France Type 1 Diabetes (T1D) Landscape Analysis

    • 9.1 France Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 9.2 France Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    10. Italy Type 1 Diabetes (T1D) Landscape Analysis

    • 10.1 Italy Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 10.2 Italy Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    11. Spain Type 1 Diabetes (T1D) Landscape Analysis

    • 11.1 Spain Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 11.2 Spain Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    12. Poland Type 1 Diabetes (T1D) Landscape Analysis

    • 12.1 Poland Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 12.2 Poland Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    13. Russia Type 1 Diabetes (T1D) Landscape Analysis

    • 13.1 Russia Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 13.2 Russia Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    14. Switzerland Type 1 Diabetes (T1D) Landscape Analysis

    • 14.1 Switzerland Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 14.2 Switzerland Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    15. Turkey Type 1 Diabetes (T1D) Landscape Analysis

    • 15.1 Turkey Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 15.2 Turkey Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 16.3.2 Finland Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 16.3.3 Norway Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 16.3.4 Sweden Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 16.3.6 Iceland Type 1 Diabetes (T1D) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 17.3.2 Netherlands Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Type 1 Diabetes (T1D) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 18.3.2 Latvia Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 18.3.3 Lithuania Type 1 Diabetes (T1D) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Bristol-Myers Squibb

      • 19.1.1 Bristol-Myers Squibb Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Sanofi

      • 19.2.1 Sanofi Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Eli Lilly

      • 19.3.1 Eli Lilly Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Astellas

      • 19.4.1 Astellas Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Lexicon

      • 19.5.1 Lexicon Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Janssen

      • 19.6.1 Janssen Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Samsung Bioepis

      • 19.7.1 Samsung Bioepis Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Merck

      • 19.8.1 Merck Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Boehringer Ingelheim

      • 19.9.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Sanofi

      • 19.10.1 Sanofi Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Janssen

      • 19.11.1 Janssen Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Merck

      • 19.12.1 Merck Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 111 Figures and 114 Tables)

    • Figure Product Picture

    • Figure Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Rapid Acting Insulin Analogs from 2014 to 2026

    • Figure Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Long Acting Insulin Analogs from 2014 to 2026

    • Figure Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • Figure Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Children from 2014 to 2026

    • Figure Europe Type 1 Diabetes (T1D) Market Size and Growth Rate of Adults from 2014 to 2026

    • Figure Germany Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure France Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Type 1 Diabetes (T1D) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Type 1 Diabetes (T1D)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Type 1 Diabetes (T1D) by Different Types from 2014 to 2026

    • Table Consumption Share of Type 1 Diabetes (T1D) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Rapid Acting Insulin Analogs

    • Figure Market Size and Growth Rate of Long Acting Insulin Analogs

    • Figure Market Size and Growth Rate of Premix Insulin Analogs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Type 1 Diabetes (T1D) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Type 1 Diabetes (T1D) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Children

    • Figure Market Size and Growth Rate of Adults

    • Table Europe Type 1 Diabetes (T1D) Production by Major Regions

    • Table Europe Type 1 Diabetes (T1D) Production Share by Major Regions

    • Figure Europe Type 1 Diabetes (T1D) Production Share by Major Countries and Regions in 2014

    • Table Europe Type 1 Diabetes (T1D) Consumption by Major Regions

    • Table Europe Type 1 Diabetes (T1D) Consumption Share by Major Regions

    • Table Germany Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table UK Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table France Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Italy Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Spain Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Poland Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Russia Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Switzerland Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Turkey Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Type 1 Diabetes (T1D) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Type 1 Diabetes (T1D) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Type 1 Diabetes (T1D) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Type 1 Diabetes (T1D) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Germany Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Germany Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Germany Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table UK Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table UK Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table UK Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table UK Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table France Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table France Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table France Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table France Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Italy Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Italy Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Italy Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Spain Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Spain Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Spain Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Poland Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Poland Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Poland Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Russia Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Russia Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Russia Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Switzerland Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Turkey Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Turkey Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Turkey Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Type 1 Diabetes (T1D) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Type 1 Diabetes (T1D) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Type 1 Diabetes (T1D) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

    • Table Company Profile and Development Status of Lexicon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lexicon

    • Figure Sales and Growth Rate Analysis of Lexicon

    • Figure Revenue and Market Share Analysis of Lexicon

    • Table Product and Service Introduction of Lexicon

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of Samsung Bioepis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Bioepis

    • Figure Sales and Growth Rate Analysis of Samsung Bioepis

    • Figure Revenue and Market Share Analysis of Samsung Bioepis

    • Table Product and Service Introduction of Samsung Bioepis

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US